>Or is my premise or conclusion flawed, especially because I missing prerequisite knowledge? Pharmaceutical-risk-based arguments aside, India is in a pretty ba

>Or is my premise or conclusion flawed, especially because I missing prerequisite knowledge? Pharmaceutical-risk-based arguments aside, India is in a pretty bad spot COVID-wise. A massive proportion of the population is dirt poor (<$1/hr) and the broader society in general don't give a damn about their plight. They cannot afford to lock down. If they do so, millions will starve to death. They were literally begging, fighting and worse to get access to oxygen tanks earlier this year. The unlucky ones watched their parents and grandparents asphyxiate in their homes with no access to treatment of any kind. If this stuff can be produced cheaply, locally and quickly, then it will be lapped up gratefully by the hundreds of millions of poor people who would be dead and buried before they got the opportunity to receive Pfizer or Moderna. What could or might happen 10 years down the track will be the least of their worries if we see another flare up.